Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-06

FDA Approved: ADEFOVIR DIPIVOXIL — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex's original application (ANDA) for Adefovir Dipivoxil, a generic antiviral for chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

ORIG AP for ADEFOVIR DIPIVOXIL (ADEFOVIR DIPIVOXIL)